John W. Glod
Associate Research Physician
Pediatric Oncology Branch, CCR
National Cancer Institute
United States of America
Dr. Glod obtained his M.D. and Ph.D. from the University of Colorado in Denver and trained in pediatrics and pediatric oncology at Cincinnati Children’s Hospital, Johns Hopkins Hospital, and the Pediatric Oncology Branch of the NCI. Following an fellowship in neuro-oncology at the NCI, Dr. Glod served as faculty in the departments of pediatrics and pharmacology at Rutgers Cancer Institute of New Jersey. Dr. Glod joined the Pharmacology and Experimental Therapeutics Section in 2013. His research interests include pediatric tumors of the central nervous system, multiple endocrine neoplasia-related medullary thyroid cancer, and neurofibromatosis-related tumors.
1) Tumors of the central nervous system, 2) Medullary thyroid cancer, 3) Neurofibromatosis-related tumors, 4) Pediatric tumors of the central nervous system, 5) Multiple endocrine neoplasia-related medullary thyroid cancer, and 6) Neurofibromatosis-related tumors.
Macrophage-associated mesenchymal stem cells assume an activated, migratory, pro-inflammatory phenotype with increased IL-6 and CXCL10 secretion.
P53 regulates the migration of mesenchymal stromal cells in response to the tumor microenvironment through both CXCL12-dependent and -independent mechanisms.
CNS lymphoma in a patient with Shwachman Diamond syndrome.